Your browser doesn't support javascript.
loading
Copy number signatures and mutational processes in ovarian carcinoma.
Macintyre, Geoff; Goranova, Teodora E; De Silva, Dilrini; Ennis, Darren; Piskorz, Anna M; Eldridge, Matthew; Sie, Daoud; Lewsley, Liz-Anne; Hanif, Aishah; Wilson, Cheryl; Dowson, Suzanne; Glasspool, Rosalind M; Lockley, Michelle; Brockbank, Elly; Montes, Ana; Walther, Axel; Sundar, Sudha; Edmondson, Richard; Hall, Geoff D; Clamp, Andrew; Gourley, Charlie; Hall, Marcia; Fotopoulou, Christina; Gabra, Hani; Paul, James; Supernat, Anna; Millan, David; Hoyle, Aoisha; Bryson, Gareth; Nourse, Craig; Mincarelli, Laura; Sanchez, Luis Navarro; Ylstra, Bauke; Jimenez-Linan, Mercedes; Moore, Luiza; Hofmann, Oliver; Markowetz, Florian; McNeish, Iain A; Brenton, James D.
Affiliation
  • Macintyre G; Cancer Research UK Cambridge Institute, Cambridge, UK.
  • Goranova TE; Cancer Research UK Cambridge Institute, Cambridge, UK.
  • De Silva D; Cancer Research UK Cambridge Institute, Cambridge, UK.
  • Ennis D; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Piskorz AM; Cancer Research UK Cambridge Institute, Cambridge, UK.
  • Eldridge M; Cancer Research UK Cambridge Institute, Cambridge, UK.
  • Sie D; VU University Medical Center, Amsterdam, the Netherlands.
  • Lewsley LA; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Hanif A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Wilson C; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Dowson S; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Glasspool RM; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Lockley M; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Brockbank E; University College London Hospital, London, UK.
  • Montes A; Barts Health NHS Trust, London, UK.
  • Walther A; Guy's Hospital, London, UK.
  • Sundar S; Bristol Cancer Institute, Bristol, UK.
  • Edmondson R; City Hospital, Birmingham, UK.
  • Hall GD; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Clamp A; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Gourley C; St James's Institute of Oncology, Leeds, UK.
  • Hall M; The Christie Hospital, Manchester, UK.
  • Fotopoulou C; Nicola Murray Centre for Ovarian Cancer Research, MRC IGMM, University of Edinburgh, Edinburgh, UK.
  • Gabra H; Mount Vernon Cancer Centre, Northwood, UK.
  • Paul J; Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College, London, UK.
  • Supernat A; Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College, London, UK.
  • Millan D; Early Clinical Development, IMED Biotech Unit, AstraZeneca, Cambridge, UK.
  • Hoyle A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Bryson G; Cancer Research UK Cambridge Institute, Cambridge, UK.
  • Nourse C; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
  • Mincarelli L; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
  • Sanchez LN; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
  • Ylstra B; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Jimenez-Linan M; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Moore L; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Hofmann O; VU University Medical Center, Amsterdam, the Netherlands.
  • Markowetz F; Addenbrooke's Hospital, Cambridge, UK.
  • McNeish IA; Addenbrooke's Hospital, Cambridge, UK.
  • Brenton JD; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Nat Genet ; 50(9): 1262-1270, 2018 09.
Article in En | MEDLINE | ID: mdl-30104763
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / DNA Copy Number Variations / Mutation Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / DNA Copy Number Variations / Mutation Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2018 Document type: Article Affiliation country: Country of publication: